SCHEMBL4872070

SCHEMBL4872070

Cc1cccc(-c2ccc3cc(-c4c(-c5ccccc5)c5sc(C(=O)O)cc5n4CC(=O)N4CCC(N5CCCC5)CC4)ccc3n2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.42
GAA P10253 1/20 0.42
TSHR P16473 1/20 0.42
NPSR1 Q6W5P4 2/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38
GRIN2B Q13224 2/20 0.38
TP53 P04637 1/20 0.38
CYP2C9 P11712 2/20 0.37
TRPV4 Q9HBA0 1/20 0.37
CBX7 O95931 2/20 0.36
CDYL2 Q8N8U2 2/20 0.36
CDYL Q9Y232 2/20 0.36
HRH3 Q9Y5N1 2/20 0.36
CDY1; CDY1B Q9Y6F8 1/20 0.36
HTT P42858 1/20 0.36
ACHE P22303 1/20 0.36
IRAK4 Q9NWZ3 1/20 0.36
PIK3CA P42336 1/20 0.35
MTOR P42345 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4877305 0.92 GRIN2B (0.43) GAANPSR1GRIN2BTP53
SCHEMBL4876791 0.92 GAA (0.39) POLBGAATSHRGRIN2BTP53
SCHEMBL4877171 0.91 PIK3CA (0.43) POLBGAATSHRTP53TRPV4
SCHEMBL4872058 0.91 GAA (0.40) POLBGAATSHRNPSR1CYP2D6
SCHEMBL4878078 0.90 GAA (0.39) POLBGAATSHRGRIN2BTP53
SCHEMBL4877296 0.90 GAA (0.40) POLBGAATSHRCYP2D6GRIN2B
SCHEMBL4874416 0.90 TRPV4 (0.40) POLBGAATSHRGRIN2BTRPV4
SCHEMBL4872449 0.90 KMT2A (0.40) POLBGAATSHRNPSR1TP53
SCHEMBL4878287 0.89 POLB (0.41) POLBGAATSHRNPSR1GRIN2B
SCHEMBL4877286 0.89 POLB (0.41) POLBGAATSHRNPSR1GRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080051384-A1 ANTIVIRAL AGENTS GENELABS TECHNOLOGIES, INC. 2008-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080051384-A1 ANTIVIRAL AGENTS EIF2AK2, MAVS, ZC3HAV1 POLB 327/4885GAA 66/4885TSHR 4492/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.